Rate Video

EBMT 2020 | Sinusoidal obstruction syndrome in patients with R/R B-cell ALL

Valentín Ortiz-Maldonado • 1 Sep 2020

Acute Lymphoblastic Leukemia Leukemia ARI-0001 CAR-T Inotuzumab ozogamicin

Valentín Ortiz-Maldonado, MD, Hospital Clinic, Barcelona, Spain, discusses sinusoidal obstruction syndrome in patients with relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (ALL) treated with ARI-0001 cells. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

CART19-BE-01: ARI-0001 in CD19+ malignancies

Valentín Ortiz-Maldonado • 11 Oct 2020

ARI-0001 CART19 cells in R/R B-ALL with isolated extramedullary disease

Valentín Ortiz-Maldonado • 3 Feb 2021

ICU admission of patients treated with ARI-0001 cells

Valentín Ortiz-Maldonado • 30 Jan 2020

Hospital exemption: enabling patients’ access to advanced therapies in the EU

Valentín Ortiz-Maldonado

Related Videos

Real-world findings of MRD by MFC in AML

Bruno Paiva • 24 Feb 2021

Impact of MMRD and ELN genetic classification in outcomes for patients with AML underoging alloHCT

Muhammad Husnain • 17 Feb 2021

SIERRA trial updates: apamistamab in AML

Tania Jain • 12 Feb 2021

CAR-T vs. BiTEs in B-cell malignancies

Marion Subklewe • 11 Feb 2021